Until recently, the idea of observing life deep within the tissues of a living mouse, at a resolution sufficient to pick out cellular behaviors and molecular signals underlying them, remained a much-coveted dream. Now, a new era of intravital fluorescence microscopy has dawned. In this Primer, we review the technologies that made this revolution possible and demonstrate how intravital imaging is beginning to provide quantitative and dynamic insights into cell biology, immunology, tumor biology, and neurobiology.
In the last two decades, there have been enormous advances in our understanding of mammalian cell biology. A variety of in vitro and ex vivo methods have been used to decipher signaling pathways, identify and exploit biological processes, and validate new drug targets. However, much of our knowledge derived from these studies is static and thus does not necessarily reflect the natural dynamics of biological processes. As such, many outstanding questions remain: How do cells behave in resting tissue, interact with one another, and exchange information? How do cells respond to pathological stimuli and mediate functions? How do specific microenvironments or combinations of factors control cell fate? And how do cells respond individually and collectively to therapeutic intervention?
Imaging of live animals at microscopic resolution (intravital microscopy, IVM) represents a powerful tool for addressing such questions. IVM can reveal cellular responses over time and space and can be conducted under conditions closely approximating those of a natural environment. This is crucial because cellular behavior is influenced by many factors including cytokine gradients, interactions with other cellular and extracellular components, anatomical compartmentalization, and forces of fluid flow. As such, cellular behavior can be very different in in vitro compared to in vivo settings.
In the past, IVM primarily involved bright-field transillumination of relatively transluscent tissues. Even centuries ago, a rudimentary form of IVM revealed that blood flow within tissues occurs via microvessels (Hoole, 1800) and that circulating leukocytes can actively extravasate into inflamed tissue (Dutrochet, 1824; Wagner, 1839) . Today, however, IVM is largely based on the detection of fluorescence and is primarily used to study the location, motility, adhesion, and interactions of individual cells in three physical dimensions over time. Progress in fluorescence labeling and detection has also opened up the field to in vivo imaging in a larger number of channels, at greater depths, for more extended periods of time, over larger tissue areas, and at vastly improved subcellular resolutions. These advances have enabled us to address some longstanding questions in cell biology. For example, recent IVM discoveries have started to elucidate how the body initiates and orchestrates innate and adaptive immune responses; how tumors control angiogenesis, invade tissues, and metastasize; and how cells in the central nervous system are interconnected and respond to local damage.
In this Primer, we explain how a convergence of technologies has not only made high-resolution IVM possible but is now putting it within the reach of increasing numbers of researchers. With this in mind, we also provide a guide for those who are interested in adding IVM to their technology toolbox (see Supplemental Information available online). We present a selection of recent advances that were obtained by IVM and highlight the current state of the art. Finally, we discuss the technical challenges and limitations that hold back current research and reveal the newly emerging technologies that may soon overcome them. The approaches presented here are intended to complement other technological advances at the single-molecule (Huang et al., 2010; Li and Xie, 2011) and macroscopic (Weissleder and Pittet, 2008; Ntziachristos, 2010 ) levels, as well as imaging of nonmammalian systems (Megason and Fraser, 2007) . In addition to enabling the inner workings of mammalian cells to be interrogated, intravital observations will ultimately impact patient care, for example by identifying and validating new drug targets and elucidating how drugs work (or why they fail). Other emerging clinical applications such as laser endomicroscopy and surgical imaging are poised to enable real-time microscopic imaging and in vivo diagnosis (Paramsothy and Leong, 2010) .
State-of-the-Heart Technology for Mouse Imaging
The major challenges of IVM are to excite fluorescence in the tissue of interest, collect the relatively low levels of in-focus light emitted from it, and separate this signal from the potentially overwhelming noise of out-of-focus light from the overlying tissue. This needs to be done with minimal damage to the tissue or the fluorophore, and with a spatial and temporal resolution sufficient to observe the behavior of individual cells. Excitation is made possible with scanning lasers that can be focused to excite fluorescence in a diffraction-limited focal volume. Although conventional confocal microsopy has the advantages of being relatively cheap and simple, its use in IVM is restricted by limited tissue penetration. The development of multiphoton microscopy has made fluorescent IVM at greater depths possible by taking advantage of the principle that a fluorophore is excited when it simultaneously absorbs two low-energy photons. In contrast to confocal microscopy, this allows the laser to selectively excite fluorescence in a specific focal plane where the two photons coincide, allowing less photobleaching, lower phototoxicity, and a reduced autofluorescence signal. Multiphoton imaging systems can also detect second harmonic signals, which are signals generated when two photons of one wavelength are absorbed and replaced by a single photon of half the wavelength. This process does not require exogenous labeling and is primarily used to visualize collagen networks.
A variety of other microscope technologies can be used to expand the range of applications of IVM. For example, ''broadband multiphoton imaging'' allows detection of a larger palette of fluorescent probes, including those that emit in the far-red region of the light spectrum (Andresen et al., 2009; Condeelis and Weissleder, 2010) . The more widely tuned lasers required for broadband imaging not only enable detection of red-shifted probes but also further increase imaging depth and can reduce photobleaching and phototoxicity. IVM can also be used to create an in vivo flow cytometer that can detect cells circulating at very high speeds. These systems involve a laser light that has been shaped into a slit across a selected vein or artery and a photomultiplier tube that samples at a sufficiently high rate as to detect fast-flowing cells (Boutrus et al., 2007) . Optical frequency domain imaging (OFDI) is another emerging technique for studying tissues continuously over time and at deeper depths (up to several millimeters into a tissue) (Vakoc et al., 2009) . OFDI capitalizes on an intrinsic mechanism of contrast based on reflectivity and can be used to acquire quantitative measurements of angiogenesis, lymphangiogenesis, and tissue viability. Finally, coherent anti-Stokes Raman scattering (CARS) microscopy allows the study of lipid distribution within a tissue (Evans et al., 2005) . Both CARS and OFDI circumvent the use of exogenous probes.
However, IVM isn't just about the microscope: equally important has been the development of suitable mouse models in which biological questions can be answered within a setting that is not only physiologically relevant but also accessible to the available technology. For example, the dorsal skin window chamber model, developed over 70 years ago, remains a widely used technique in cancer research (Brown et al., 2001) . Mice with implanted window chambers can be maintained for several weeks, allowing imaging over extended periods. To image the brain, either thinning of the skull with a drill under a dissecting microscope (Grutzendler et al., 2002) or the execution of small craniotomy (Davalos et al., 2005) is necessary. For imaging deeper within tissues, optical fibers can be implanted after craniotomy (Barretto et al., 2011) . The skull itself provides another useful system for visualizing the dynamics of hematopoietic stem cells: the skull bone marrow model (Mazo et al., 1998) exploits the delicate nature of the frontoparietal skull bone of the mouse, which is <100 mm thick and thus sufficiently transparent for multiphoton penetration (Lo Celso et al., 2011) . Other organs can be made more accessible though surgical procedures with variable degrees of invasiveness. The popliteal lymph nodes can be visualized through a small skin incision , whereas the liver is exteriorized and superfused with physiological saline solution before imaging (Egen et al., 2011; Wong et al., 2011) . Models for other organs, such as the kidney, pancreas, spleen, and heart, are less well developed and at a greater risk of artifacts such as inflammatory reactions. In every model system, muscle contractions, respiration, and blood vessel pulses can cause movements that need to be restrained through a combination of deep anesthesia and some form of physical immobilization.
The third technology that has massively enhanced the power of IVM is the development of new fluorescent probes. With a few exceptions (listed above), the vast majority of IVM studies use fluorescent proteins (FPs) and/or exogenous fluorochromes to generate image contrast. A large number of genetically encoded fluorescent probes (such as cleavable or photoactivatable/switchable proteins) are now available. Although IVM demands reporters that can achieve very high signal-to-noise ratios, minimizing the time required to expose the animal to the laser while collecting sufficient light to construct a high-resolution image, enhanced probes have been developed with this need in mind. Fluorescent dyes are also particularly important for IVM. Some of these agents are used to stain cells ex vivo before adoptive transfer (e.g., CMTMR, red; CFSE, green; and Hoechst 33342, blue), whereas other fluorescent probes can be injected directly into the animal and enable visualization of endogenous structures (e.g., blood vessels and lymph via Angiosense, fluorescent dextrans, and quantum dots), cell populations (e.g., monocytes and macrophages via iron oxide nanoparticles), and enzymatic activities (e.g., cathepsins via Prosense and metalloproteinases via MMPsense) (Michalet et al., 2005; Weissleder and Pittet, 2008) . Increasingly, reactive fluorochromes and quantum dots are being employed to label antibodies and other proteins. Newer fluorochromes (Budin et al., 2011; Reiner et al., 2010) are now available, with increased cell permeability, biocompatibility, and optimized pharmacokinetics for efficient in vivo use.
Current Applications of Intravital Microscopy
How have these converging technologies been applied to key questions in biology? In this section, we focus primarily on the cell's cardinal attributes: division, death, migration, communication, and fate. Although the examples presented are mainly derived from studies of cancer and immunology, the same techniques can be applied to other disciplines. Indeed, IVM has been used in many areas of research including neural, stem cell, developmental, reproductive, ocular, cutaneous, cardiovascular, and infectious disease biology (additional information on the use of IVM across disciplines is available in the Supplemental Information). In particular, neurobiology has the earliest reported multiphoton IVM studies and continues to actively employ IVM to study the etiology and therapeutics of neurological diseases. With further technological developments, it is likely that the use of IVM will extend to many other disciplines. Cell Division A fundamental feature of cancer cells is their ability to sustain proliferative growth. Original IVM studies of tumor cell proliferation were limited to the detection of cell division of a single parent cell into two (or more) daughter cells. However, with the advent of higher-resolution imaging and the capacity for fluorescently labeling multiple intracellular components, mitosis can now be studied in more detail (Figure 1 ). For example, tumor cells labeled with specific tags for histone H2b and a-tubulin can be used to follow nuclear morphology in vivo (Orth et al., 2011) . From these studies, it was clear that cell division proceeds at a similar speed and sequence in vivo as it does in vitro; however, the initiation of mitosis in vivo was found to be a far less frequent event than it was in vitro. Other IVM reporters currently in use include FUCCI (APC.Cdh1 [G1]; Scf.Skp2 [S,G2]) (Sakaue-Sawano et al., 2008) and Ki67-XFP. These tools are now available for investigating questions such as, how is tumor cell proliferation controlled by stromal interactions and by exposure to vasculature? Does cell division contribute to other processes such as invasion? What effects do drugs have in vivo? Can quantitative and predictive models of cell amplification be developed (see below)? Cell Death A variety of apoptosis readouts have become available or are under investigation for in vivo imaging ( Figure 1 ). One in vivo readout of cell death consists of administering mice with target cells previously labeled with both a cytoplasmic and a nucleic dye (Mempel et al., 2006) ; this approach has been used to define the outcome of physical interactions between surrogate tumor cells and cytotoxic T lymphocytes. Because a lethal hit by the lymphocyte leads to a measurable change in the cytoplasmicto-nucleic fluorescent ratio of the target cell, time-lapse IVM allows the status (dead or alive) of target cells to be tracked over time. However, this approach limits detection of cell death following fresh cell injection. Other readouts make use of Foerster resonance energy transfer (FRET) reporters of caspase activity (CFP-DEVD-YFP) (Breart et al., 2008) , mitochrondrial membrane-fusion proteins (IMS-XFP) that change shape during mitochondrial outer membrane permeabilization (MOMP) (Albeck et al., 2008) , Bcl2-XFP fusion proteins (Wang et al., 2001) , or turn-on XFP reporters (Nicholls et al., 2011) . Nuclear morphology can also be assessed using H2B-XFP (Orth et al., 2011) . Changes in nuclear morphology detected by H2B-XFP (in combination with a-tubulin-XFP) during cell death include multinucleation, cell-cycle arrest, or abnormal (bipolar, multipolar) mitosis. Other cell viability IVM readouts include the measurement of p53 DNA-damage reporters (P53BP1-XFP) (Giesen et al., 2011) or the use of LC3-XFP mice (Tian et al., 2010) to track autophagy. Drug-induced cell death and Cell death. Top: Cell death reporters. From left to right: H2b-XFP (nuclear morphology) (Orth et al., 2011) ; IMS-XFP (mitochondrial outer membrane permeabilization); Bcl2-XFP (apoptosis signaling); and LC3-XFP (autophagosomes). Bottom left: Target cell (red cytoplasmic marker, blue nucleus) killing by a cytotoxic T lymphocyte (green). Loss of cell membrane integrity results in a decreased red/blue ratio. Images reproduced from Mempel et al. (2006) . Bottom right: Cytotoxic T lymphocyte-mediated tumor cell apoptosis detected using a FRET-based reporter of caspase 3 activity. Live tumor cell: orange; apoptotic tumor cell: green; cytotoxic T lymphocyte: red. Images reproduced from Breart et al. (2008) . Cell migration. Left: Single-cell tracks (top) and quantification of cell displacement (bottom) of reservoir splenic monocytes in response to a distant injury. Right: Extravasation of a splenic monocyte for redistribution to distant tissues. Images reproduced from Swirski et al. (2009) . Cell communication. Top: Rare long-lasting physical interactions between two immune cell types (images reproduced from Mempel et al., 2006) . Bottom: A lymph node dendritic cell interacting with five different lymphocytes, with quantification of interaction times between different cell types. mechanisms of apoptosis regulation in vivo (Spencer et al., 2009; Spencer and Sorger, 2011) are other fields in which IVM research is emerging. Cell Migration Extensive in vitro work has already defined how the anchoring of a cell membrane to extracellular substrates allows intracellularly generated forces to be translated into cell locomotion. Now, with the use of multiphoton IVM, cell migration can be studied directly in vivo (Figure 1 ). With this system, infrared excitation enables deeper imaging into tissues, whereas laser scanheads allow stacks of two-dimensional optical tissue sections to be obtained; these sections can then be digitally assembled into three-dimensional datasets. Repeated imaging at defined intervals thus enables cells' migratory path, velocity, motility, chemotactic index, and physical interactions with other tissue components to be determined (Sumen et al., 2004) . Using this generic approach, migration of multiple cell types can be studied, including cancer cells, stem cells, as well as various immune cell populations. One issue that has received particular attention is whether cell migration in tissue is random or directional (reviewed in Pittet and Mempel, 2008) . In answer to this question, a recent IVM study provided evidence to suggest that cell migration through tissue relies on the sole force of actin-network expansion (Lä mmermann et al., 2008) . Thus, in contrast to earlier in vitro findings, migration in vivo can occur in the absence of specific adhesive interactions with the extracellular environment. Other studies have indicated that the motility of naive T lymphocytes in lymph nodes depends on chemokine receptor-ligand interactions (Okada and Cyster, 2007; Worbs et al., 2007) , even though the directionality of migration seems not to be influenced by chemokine gradients (Miller et al., 2003) . Chemokines do however direct the migration of leukocytes in certain situations. For example, chemotaxis has been shown in lymph node B cells that, following antigen priming and functional reprogramming, migrate along a CCR7 ligand gradient toward the T cell zone; this process results in initiation of T cell-dependent humoral immune responses (Okada et al., 2005) .
IVM studies of cancer and morphogenesis have likewise demonstrated that cells can sometimes migrate as a cohesive group. This process, known as ''collective cell migration,'' involves the movement of cells that are physically connected via cell-cell junctions. Within this group, the leader cell may facilitate migration not only by participating in chemotaxis but also by exhibiting proteolytic activity. Attached cells are thus dragged along a remodeled matrix track (Alexander et al., 2008; Giampieri et al., 2009) . IVM can also be used to investigate cell mobilization from one tissue to another. For example, IVM has recently been used to study the mobilization of both adaptive (Mrass et al., 2006; Boissonnas et al., 2007) and innate (Auffray et al., 2007; McDonald et al., 2010; Swirski et al., 2009 ) immune cells to sites of inflammation. Cell Communication Cells communicate constantly with their environment either by releasing and sensing soluble factors or by initiating physical interactions. These processes are of significant importance as they have the power to influence key cell parameters such as proliferation, survival, and motility, as well as regulate effector functions. However, cell communication and its functional consequences remain difficult to probe in vivo (see Current Limitations and Emerging Technologies below). At present, IVM studies are typically limited to the tracking of whole cells (rather than their molecular activities) and thus need to be complemented using ex vivo approaches. Existing IVM approaches have nevertheless already elucidated many important facets of cell-cell interactions through the systematic comparison of two or more experimental conditions (e.g., wild-type versus knockout animals, or animals with/without defined cell populations).
A considerable body of knowledge regarding microenvironmental cellular networks has accumulated from immunology studies (Figure 1 ). For example, unlike previous in vitro findings, IVM investigations of lymphocyte activation have revealed that naive T cells in lymph nodes of anesthetized mice continuously migrate and scan antigen-presenting dendritic cell populations (Miller et al., 2003; Mempel et al., 2004) . These (and other) results have helped to explain how lymphocytes optimize their chances of encountering rare cognate antigens and initiate adaptive immune responses (Bousso, 2008 (Tang et al., 2006) . IVM has also been used as a tool for characterizing the invasive tumor microenvironment. For example, in breast cancer models, perivascular macrophages have been shown to directly communicate with cancer cells and to facilitate their migration and intravasation (Wyckoff et al., 2004) . Second, harmonic imaging has further revealed that the migration of tumor cells and macrophages occurs along collagen fibers, a finding which has served to confirm that components of the extracellular matrix are important to the invasive microenvironment (Roussos et al., 2011) . IVM studies using a model of brain metastasis have indicated that premetastatic circulating tumor cells often arrest at vascular branch points and extravasate through small holes in the vascular wall, where they typically remain within the close vicinity of microvessels. Here, tumor cells act to induce perivascular growth either by vessel co-option or by angiogenesis (Kienast et al., 2010) . Another study has likewise revealed a key role of macrophages during the metastatic process (Qian et al., 2009) . By tracking several cell populations simultaneously, IVM technologies have allowed us to advance our overall understanding of the tumor microenvironment. It is likely that IVM technologies will also be invaluable in determining how host cell networks respond to anticancer drugs, which in turn may advance current therapeutic options.
There is an ongoing effort toward developing technologies that will extend our ability to study cell communication, such that specific outcomes following cellular interactions are detectable at the molecular level. For example, cellular calcium fluxes can be monitored in vivo and have been used as a measure of membrane depolarization during neuronal activity (Svoboda et al., 1997) . Calcium fluxes have also been used as an indicator of antigen stimulation following the engagement of B cells with dendritic cells in lymph nodes (Qi et al., 2006) . Furthermore, a transgenic mouse expressing a T cell receptor (TCR)-GFP fusion protein has recently been developed to enable the visualization of TCR clustering and internalization following their encounter with antigen on dendritic cells (Friedman et al., 2010) . Other technologies for molecular imaging at subcellular resolution will likely emerge within the next decade. Cell Fate IVM is a useful tool for tracking the behavior of individual cells over relatively short timeframes (several hours) and within a relatively confined environment (<0.1 mm 3 ). In general, however, IVM does not allow the same cells to be tracked for longer periods (days to weeks) or in areas away from the region originally imaged. Fortunately, these limitations may soon be overcome by new emerging methods. One approach involves selectively tagging a small fraction (e.g., 1 to 100 cells) of cells of interest directly in vivo and then following the fate of these cells at a particular time and place (Figure 2A) . Such selective in vivo tagging can be achieved using cells that code for a photoswitchable protein, such as Dendra2. Prior to photoswitching, Dendra2 resembles GFP in its spectrum, but on exposure to light (e.g., 405 nm), an irreversible red shift of >150 nm in the excitation and emission spectra of the fluorophore occurs. Following the photoswitch, the red fluorescence increases by 250-fold, which allows the selected cells to be distinguished for at least 5 days (after which, cell proliferation and protein turnover eventually dilute the photoswitched protein). This photoswitching approach has already been successfully employed for studying primary cancer cell colonization at distant organs in an orthotopic mammary mouse cancer model. Findings from this study revealed that distinct tumor microenvironments exhibit different rates of tumor cell invasion and intravasation where, for instance, the tumor perivascular environment selectively promotes tumor metastatic behavior (Kedrin et al., 2008) . This approach has also enabled detection of photoswitched cells that have migrated to metastatic sites. PSmOrange ( Figure 2B ) is another example of a photoswitchable protein, in which irradiation causes a color change from orange to far-red (Subach et al., 2011) . The existence of such photoswitchable proteins with distinct optical properties now opens up avenues for tracking the fates of several cell populations simultaneously.
Another significant advancement has been the introduction of genetic constructs for labeling clonal cell populations with distinct colors. The initial technology, known as Brainbow (Livet et al., 2007) , used a Cre/lox recombination system that stochastically defines the expression of multiple copies of constructs coding for diverse fluorescent proteins ( Figure 2C ). The process creates a mosaic of up to 90 distinguishable colors, which can then be stably defined. This system has already been used to label and detect individual adjacent neurons, their connectivity, as well as the fate and interactions of cells over time in vivo. In principle, the Brainbow cassettes are adaptable to any cell type sensitive to site-specific recombinases. An alternative recombination strategy, known as RGB marking, uses lentiviral gene ontology (LeGO) vectors encoding red, green, and blue fluorescent proteins (Weber et al., 2011) . In this system, RGBcoded cell populations can be tracked by IVM following adoptive transfer ( Figure 2D ). Both the Brainbow and LeGO technologies appear well suited to following clonal histories of cell populations and will thus likely be useful for addressing biological questions from a variety of disciplines.
Fluorescent reporter assays have also been developed to detect gene activation (or inactivation) based on the expression of certain fluorescent proteins. For example, a bicistronic fluorescent reporter that allows visualization of interferon-gamma gene activation has been used to observe early diversification of T lymphocyte responses following antigen priming in lymph nodes (Beuneu et al., 2010) .
The above-described in vivo readouts will likely complement genetic approaches that use unique molecular identifiers, e.g., to follow hematopoietic stem cells and their progeny (Lu et al., 2011) or to track primary tumors and their related metastases (Winslow et al., 2011) . In the latter cancer study, specific alterations in gene expression were identified that could distinguish metastatic from nonmetastatic tumors. It would be interesting to now investigate such differences further via IVM.
Vascular Networks
Tumor progression and metastases are dependent on the formation of new blood vessels; these support the tumor's nutrient and oxygen needs, allow delivery of tumor-supporting host cells, and enable tumor cells to be disseminated to distant organs. With the advent of multiphoton microscopy, it has become possible to perform time-lapse studies in three dimensions of relatively deep-seated (up to 300 mm) tumor tissue (Brown et al., 2003) . This has enabled measurement of hemodynamics, vessel permeability, and drug delivery to tumors, as well as of vascular responses to therapy. Blood vessels are typically visualized following the intravenous injection of fluorescent agents with relatively long blood half-lives. The additional visualization of endothelial cells involves the use of transgenic animal models (e.g., TIE2-XFP) or in vivo labeling with fluorescent lectins or antibodies. It is likely that future IVM studies will not only enhance our mechanistic understanding of vascular networks but also enable identification of optimal treatment regimens (dosage, duration, novel antiangiogenic drug combinations), which eliminate and/or normalize tumor blood vessels in patients (Carmeliet and Jain, 2011) . Having the ability to study dynamic changes over larger areas and over prolonged periods will also enable us to observe the unfolding of drug responses within the heterogeneous tumor environment. OFDI is one example of a new IVM technology that could be useful for such studies because it allows tissue vessels to be observed at greater depths (Vakoc et al., 2009 ).
Current Limitations and Emerging Concepts
The maturity of today's IVM technology enables us to revisit long-standing biological paradigms--and address new ones--by submitting specific hypotheses to direct in situ observation, across a variety of research disciplines. However, a sustained effort is required if we are to fully realize the promise of higher-resolution microscopy for the study of in vivo biology, pathophysiology, and pharmacology. Although experimental challenges still exist, they also provide a community-wide opportunity for the development of new tools and approaches.
Better Assessment of Biological Complexity
The IVM studies highlighted in this Primer are intended to demonstrate the exceptional capacity and ongoing potential of new imaging techniques for studying cell biology directly in vivo. The readouts currently used, however, are not always capable of capturing the full complexity of biological events. Indeed, to date, most of the components within a tissue analyzed by IVM continue to remain ''unseen.'' Thus, having the ability to examine a wider range of relevant parameters will no doubt enhance our understanding of how tissues are organized and how single cells receive and provide information. Although the factors requiring simultaneous assessment may be different for each investigation, they will likely involve a combination of cell types (stromal cells, immune cells, others), structural components (extracellular matrix, vessels, nerves), and chemical mediators (cytokines, lipids, enzymes). Below we discuss how this goal might be achieved.
First, new mouse genetic models are required to enable greater numbers of endogenous constituents to be studied simultaneously. These are dependent on the use of genetic fluorescent reporters that can be spectrally resolved (Shaner et al., 2005) . Although the concomitant incorporation of several imaging constructs into transgenic mice is relatively timeconsuming, it will likely be of huge value. In particular, we expect that future IVM cancer studies will employ pre-existing mouse conditional genetic tumor models (DuPage et al., 2009) . Because cancers in these mice closely recapitulate the human disease, the addition of imaging reporters will allow the disease to be investigated more closely than is currently possible using tumor cell lines. The detection of fluorescence across a wider range of wavelengths and the implementation of additional imaging channels for detection of multiple biosensors are other possible options.
Second, new technologies are needed for refining our analysis of the cell's major molecular pathways, biological processes, and drug targets. This could be achieved by developing cell lines and mouse models with relevant fluorescent reporters (e.g., fusion proteins [Friedman et al., 2010] or FRET sensors [Breart et al., 2008] ) or with cell-permeable and fluorescent drugs that have molecular specificity (Budin et al., 2011; Reiner et al., 2011) . Although injectable probes hold the potential for translation into human use, their validation will require careful in vivo testing (Weissleder and Pittet, 2008) . Our capacity to visualize molecular activities by IVM will also require validation of the sensitive microscope hardware, which is capable of detecting fluorescent reporters expressed at physiological levels. It is possible that quantum dots with long excitation lifetimes will be useful for attaining this goal.
Other variables will likewise require in vivo scrutiny. For example, current IVM technologies do not permit dynamic high-resolution imaging of all tissues, and of the tissues that can be imaged, it is not always possible to do so deeply. Improvements to current technology could be achieved through the development of engineering methods that reduce physiologic motion, allow deeper photon penetration, and/or enable closer access to the tissue (for example, via stick objectives or microendoscopes). Promising efforts to improve penetration depth include the use of far-red probes and longer wavelength lasers (Andresen et al., 2009; Condeelis and Weissleder, 2010) and/or adaptive optics (Rueckel et al., 2006) . Current IVM methods are also not generally able to image large areas of tissues. Methods that can integrate meso-and microscopic information would thus be useful for resolving the heterogeneity of tissue components at a larger scale. Moreover, the speed at which optical tissue sections are presently scanned not only limits the time resolution in volume imaging but typically allows only relatively slow dynamic processes to be observed. Methods that increase image collection rates should facilitate the tracking of fast-moving objects in less restricted tissue volumes. Finally, the ability to track single cells over prolonged periods (weeks or months) is currently limited. The above-mentioned Brainbow and LeGO approaches offer potentially valuable options for overcoming this limitation. Analysis of Drug Responses at the Single-Cell Level Systems biologists, primarily in academia, are currently modeling molecular pathways at a cellular level to predict the effects of perturbation. In parallel, pharmacologists, many in industry, are working toward advancing models of disease, pharmacokinetics, and pharmacodynamics; these typically involve coarse grained multicompartment models corresponding to blood, cancer, and major organs. IVM is now emerging as an important tool for connecting these levels of analysis, enabling more reliable pharmacokinetics/pharmacodynamics information and thus a better understanding of the action and failure of drugs.
In a recent study, high-resolution IVM was used to assess the effects of the mitotic inhibitor Paclitaxel on tumor cells in vivo. Observations included defective spindle assembly, subsequent mitotic arrest, slippage, multinucleation, and apoptosis, all of which were readily detectable in individual cancer cells (Orth et al., 2011) . The morphologies of mitotic defects induced by the drug were both dose and time dependent and could therefore be used to determine semiquantitative, single-cell measures of pharmacodynamics. In response to Paclitaxel, tumor cells in mice showed a much lower peak mitotic index than those in cell culture. Indeed, surprisingly, many tumor cells did not progress past mitotic arrest, even in conditions where the drug triggered significant tumor regression. Furthermore, unlike in culture where tumor cells underwent apoptosis, tumor cells in the mice survived longer after mitotic arrest and became multinucleated rather than dying; this suggests that the environment in vivo can be much less proapoptotic and that our understanding of the real impact of drugs in vivo remains relatively limited.
Future studies designed to address the above issues will likely make use of emerging bioorthogonal chemistries, which can fluorescently ''tag'' drug analogs (Figure 3) , and thus enable measurements of pharmocokinetics by IVM (Reiner et al., 2010; Budin et al., 2011) . Using such chemistries, it is now possible to assess in vivo drug distribution across a variety of cellular (including intracellular) compartments. Major goals will be to both define the final destination of specific drugs (e.g., in tumor cells or in non-neoplastic tumor-associated stromal components) and determine the effects of drugs on heterogeneous cell populations and distinct microenvironments. New mathematical models of drug distribution and response will also be of value. Such models could be used to fill in ''missing data'' from intravital time series, provide insights into doseresponse relationships at the single-cell level in whole tissues, and then link information on drug exposure to molecular models of drug response pathways. Data Extraction, Automation, Modeling, Integration, and Visualization Currently available computing tools allow information from IVM datasets to be extracted and quantified. However, there is still a need for improved data standards, better techniques for segmenting images and quantifying information, new methods for data incorporation into mathematical models, and more flexible, reliable, and distributed data management systems. Moreover, the extraction of quantitative data from intravital image sequences is often still done manually and can be laborious to perform. Automated tools are thus needed to enable more sophisticated segmentation and tracking of cells, both in three dimensions and in whole tissues. Ultimately having the ability to manage large datasets ''on the fly,'' perform complex reconstructions in real time, and achieve automated microscopic image stitching of three-dimensional tissue areas would be useful. There is therefore a need for new approaches that not only integrate and manipulate multiscale image data but also extract precise numerical information to allow cellular circuits at different levels of cellular and molecular detail to be mapped and modeled. It is likely that the achievement of this goal will require a synthesis of previous knowledge together with information gained from highthroughput screens, in vivo imaging, and direct experimental tests of key hypotheses in relevant in vivo animal models. Such computational methods could eventually be used to assess whether the topology or dynamics of pathways in certain cell phenotypes can predict natural outcomes or drug responses. 
